Dashboard
Manage Tickers

PRTKParatek Pharmaceuticals, Inc.

Nasdaq paratekpharma.com


$ 2.23 $ 0.04 (1.83 %)    

Wednesday, 20-Sep-2023 15:59:50 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 435.98 $ 8.58 (2.01 %)
DIA $ 386.87 $ 4.54 (1.19 %)
SPY $ 511.25 $ 6.26 (1.24 %)
TLT $ 89.88 $ 0.90 (1.01 %)
GLD $ 212.97 $ -0.17 (-0.08 %)
$ 2.23
$ 2.20
$ 2.18 x 300
$ 2.25 x 4,300
$ 2.20 - $ 2.23
$ 1.29 - $ 3.65
4,764,401
na
127.74M
$ 1.33
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-03-2023 06-30-2023 10-Q
2 05-09-2023 03-31-2023 10-Q
3 03-16-2023 12-31-2022 10-K
4 11-03-2022 09-30-2022 10-Q
5 08-03-2022 06-30-2022 10-Q
6 05-04-2022 03-31-2022 10-Q
7 03-14-2022 12-31-2021 10-K
8 11-08-2021 09-30-2021 10-Q
9 08-09-2021 06-30-2021 10-Q
10 05-17-2021 03-31-2021 10-Q
11 03-29-2021 12-31-2020 10-K
12 11-05-2020 09-30-2020 10-Q
13 08-10-2020 06-30-2020 10-Q
14 05-11-2020 03-31-2020 10-Q
15 03-10-2020 12-31-2019 10-K
16 11-12-2019 09-30-2019 10-Q
17 08-06-2019 06-30-2019 10-Q
18 05-08-2019 03-31-2019 10-Q
19 03-06-2019 12-31-2018 10-K
20 11-06-2018 09-30-2018 10-Q
21 08-02-2018 06-30-2018 10-Q
22 05-09-2018 03-31-2018 10-Q
23 03-06-2018 12-31-2017 10-K
24 11-08-2017 09-30-2017 10-Q
25 08-02-2017 06-30-2017 10-Q
26 05-04-2017 03-31-2017 10-Q
27 03-02-2017 12-31-2016 10-K
28 11-02-2016 09-30-2016 10-Q
29 08-04-2016 06-30-2016 10-Q
30 05-02-2016 03-31-2016 10-Q
31 03-09-2016 12-31-2015 10-K
32 11-12-2015 09-30-2015 10-Q
33 08-11-2015 06-30-2015 10-Q
34 05-15-2015 03-31-2015 10-Q
35 04-02-2015 12-31-2014 10-K
36 10-28-2014 09-30-2014 10-Q
37 08-06-2014 06-30-2014 10-Q
38 05-05-2014 03-31-2014 10-Q
39 03-14-2014 12-31-2013 10-K
40 11-07-2013 09-30-2013 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

paratek-pharmaceuticals-announces-stockholder-approval-of-acquisition-by-gurnet-point-capital-and-novo-holdings-as
Paratek Pharmaceuticals Announces Stockhol...
09/18/2023 13:39:01

Paratek Pharmaceuticals, Inc. ("Paratek") (NASDAQ:PRTK), a commercial-stage biopharmaceutical company focused on the de...

paratek-pharmaceuticals-received-six-demands-made-pursuant-to-section-220-of-delaware-general-corporation-law-seeking-certain-booksrecords-of-co-without-admitting-any-liability-or-wrongdoing-co-is-making-supplemental-disclosures-to-proxy-statement
Paratek Pharmaceuticals Received Six Deman...
09/11/2023 11:57:19

hc-wainwright--co-reiterates-neutral-on-paratek-pharmaceuticals-maintains-215-price-target
HC Wainwright & Co. Reiterates Neutral on ...
08/07/2023 10:57:08

HC Wainwright & Co. analyst Ed Arce reiterates Paratek Pharmaceuticals (NASDAQ:PRTK) with a Neutral and maintains $2.15 ...

paratek-pharmaceuticals-total-revenue-for-q2-fy23-was-40m-compared-to-296m-for-the-same-period-in-the-prior-year-beating-the-consensus-of-3385m
Paratek Pharmaceuticals' Total Revenue For...
08/03/2023 12:25:14

paratek-pharmaceuticals--stockholders-to-receive-upfront-cash-payment-of-215-per-share-and-a-contingent-value-right-of-085-per-share-on-achievement-of-a-commercial-milestone-for-a-total-potential-value-of-300-per-share
Paratek Pharmaceuticals Stockholders To R...
08/02/2023 21:41:10

paratek-pharmaceuticals-files-definitive-proxy-statement-and-letter-to-stockholders-in-connection-with-acquisition-by-gurnet-point-capital-and-novo-holdings
Paratek Pharmaceuticals Files Definitive P...
08/02/2023 21:41:03

Transaction Provides Paratek Stockholders with Immediate Value and Liquidity   Stockholders to Receive Upfront Cash Payment of...

hc-wainwright--co-reiterates-neutral-on-paratek-pharmaceuticals-maintains-215-price-target
HC Wainwright & Co. Reiterates Neutral on ...
07/10/2023 15:21:59

HC Wainwright & Co. analyst Ed Arce reiterates Paratek Pharmaceuticals (NASDAQ:PRTK) with a Neutral and maintains $2.15 ...

paratek-pharmaceuticals-announces-modification-of-barda-contract-to-advance-the-development-of-nuzyra-for-post-exposure-prophylaxis-and-treatment-of-pulmonary-anthrax
Paratek Pharmaceuticals Announces Modifica...
07/10/2023 12:04:26

-- Third procurement to be split into two procurements based on the achievement of specific anthrax development milestones -- ...

paratek-pharmaceuticals-acknowledges-receipt-of-nexpoint-letter-says-cos-board-of-directors-respectfully-disagrees-with-nexpoints-characterizations-contained-in-its-letter
Paratek Pharmaceuticals Acknowledges Recei...
06/27/2023 16:04:06

 Paratek Pharmaceuticals, Inc. ("Paratek") (NASDAQ:PRTK), a commercial-stage biopharmaceutical company focused on the d...

paratek-pharmaceuticals-announced-that-the-european-medicines-agency-committee-for-orphan-medicinal-products-has-recommended-positive-opinion-for-orphan-medicinal-product-designation-for-nuzyra-omadacycline-for-nontuberculous-mycobacterial-lung-disease
Paratek Pharmaceuticals Announced That The...
06/27/2023 12:06:17

Core News & Articles
Benzinga's Top Ratings Upgrades, Downgrade...
06/07/2023 15:00:39

hc-wainwright--co-downgrades-paratek-pharmaceuticals-to-neutral-announces-215-price-target
HC Wainwright & Co. Downgrades Paratek Pha...
06/07/2023 10:50:58

HC Wainwright & Co. analyst Ed Arce downgrades Paratek Pharmaceuticals (NASDAQ:PRTK) from Buy to Neutral and announces $...

jefferies-downgrades-paratek-pharmaceuticals-to-hold-lowers-price-target-to-215
Jefferies Downgrades Paratek Pharmaceutica...
06/07/2023 09:19:54

Jefferies analyst Suji Jeong downgrades Paratek Pharmaceuticals (NASDAQ:PRTK) from Buy to Hold and lowers the price target f...

why-paratek-pharmaceuticals-stock-is-up-today
Why Paratek Pharmaceuticals Stock Is Up Today
06/06/2023 19:38:02

Shares of Paratek Pharmaceuticals, Inc. (NASDAQ: PRTK), a commercial-stage biopharmaceutical company, are up Tuesday after the ...

paratek-pharmaceuticals-agrees-to-be-taken-private-by-gurnet-point-and-novo-holdings-for-462m
Paratek Pharmaceuticals Agrees To Be Taken...
06/06/2023 16:42:00

paratek-pharmaceuticals-to-be-acquired-by-gurnet-point-capital-and-novo-holdings-for-3share-including-upfront-payment-of-215share-total-transaction-consideration-of-up-to-462m
Paratek Pharmaceuticals To Be Acquired by ...
06/06/2023 13:09:44

paratek-pharmaceuticals-shares-halted-news-pending
Paratek Pharmaceuticals Shares Halted, New...
06/06/2023 12:41:01

paratek-pharmaceuticals-jumps-amid-report-about-takeover-interest-gurnet-point-capital-is-said-to-be-one-of-the-pe-firms-circling-the-company-according-to-a-betaville-rare-alert
"Paratek Pharmaceuticals Jumps Amid Report...
06/01/2023 19:23:45

- SA

recap-paratek-pharmaceuticals-q1-earnings
Recap: Paratek Pharmaceuticals Q1 Earnings
05/09/2023 20:15:22

paratek-pharmaceuticals-q1-eps-035-misses-033-estimate-sales-3124m-miss-3377m-estimate
Paratek Pharmaceuticals Q1 EPS $(0.35) Mis...
05/09/2023 20:15:00

Paratek Pharmaceuticals (NASDAQ:PRTK) reported quarterly losses of $(0.35) per share which missed the analyst consensus estimat...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION